Analyst Report: STZ
1. EXECUTIVE SUMMARY
Constellation Brands closed at $126.40 on Monday 12 October, up 11.55% over the week from $113.31, after a fiscal Q2 2027 report that beat consensus and a management comment that September trends could lift full-year results toward the upper end of guidance. The company reported adjusted EPS of $3.74 on $2.63 billion in revenue against expectations of $3.56 and $2.54 billion (CNBC), and kept its fiscal 2027 guidance. Most of the gain came in three sessions from 6 to 8 October on volume of 5.3 to 6.3 million shares, roughly two to three times the 50-session average. The 8 October session rose 4.43% even though several brokers cut price targets and HSBC downgraded the stock. The 12 October gain of 3.07% has no sourced driver. Depletions fell 0.6% in the quarter, and the guidance implies a weaker second half, so the rally rests on a recovery in September trends that is not yet confirmed in the reported numbers.
2. THE CATALYST
The stock rose before any results were out. Benzinga (5 October) flagged an 11-year low and TradingView (6 October) described the cheapest valuation in over a decade, and the shares closed up 2.08% on 6 October on 6.07 million shares. That session came ahead of the release, so it reflects positioning and not company news inferred from the print.
The company reported after the close on 6 October at about 4:05pm EDT and held its call at 8:00am ET on 7 October (Constellation IR). The figures:
| Item | Reported | Consensus (CNBC) |
|---|---|---|
| Adjusted EPS | $3.74 | $3.56 |
| Revenue | $2.63bn | $2.54bn |
Other details from the release:
- Beer revenue rose 5% to about $2.47 billion on shipment growth of 5.5%, while depletions slipped 0.6% (Yahoo Finance/CNBC).
- Management attributed the depletion miss to the World Cup and August macro pressure, and shipments ran ahead of Goldman's estimate as distributors rebuilt inventory (Investing.com).
- Constellation said September trends could lift fiscal 2027 results toward the upper end of guidance (Stocktwits, 7 October).
Session by session:
| Date | Close | Change | Volume | Sourced driver |
|---|---|---|---|---|
| 6 Oct | $115.67 | +2.08% | 6,072,600 | Pre-earnings positioning at a decade-low valuation |
| 7 Oct | $118.39 | +2.35% | 6,339,300 | Beat, plus the September trend comment on the call; premarket had pointed about 5% lower (Investing.com) |
| 8 Oct | $123.63 | +4.43% | 5,266,100 | Likely RBC's note on September depletion improvement beyond Labor Day (Yahoo Finance); only a summary was read |
| 9 Oct | $122.64 | -0.80% | 2,378,400 | No in-window news found |
| 12 Oct | $126.40 | +3.07% | 2,393,000 | Unexplained |
The brief found no source explaining why the 7 October session reversed from a lower premarket. The SpikedAde acquisition announced on 6 October ($75 million at close, up to $278 million of contingent consideration over five years) does not affect the fiscal 2027 outlook (8-K), so it was not the driver.
3. COMPANY PROFILE
Constellation Brands is a Consumer Defensive company in the brewers industry. It produces, imports, markets and sells beer, wine and spirits in the United States, Canada, Mexico, New Zealand and Italy. Its beer portfolio includes Corona Extra, Modelo Especial and Pacifico, and its wine brands include Kim Crawford and Ruffino. The market capitalisation is $21.39bn.
Q2 fiscal 2027 results (StockTitan filing summary):
- Net sales were $2.633bn, up 6%.
- Diluted GAAP EPS was $3.32, up 25%, and comparable EPS was $3.74, up 3%.
- GAAP operating income fell 8% to $805.0 million.
- About $400 million was returned to shareholders through buybacks and dividends.
Guidance for the fiscal year ending 28 February 2027 was reaffirmed at comparable EPS of $11.20 to $11.90 and reported EPS of $11.85 to $12.55. According to Investing.com, holding that range implies a second-half beer net sales decline of about 4.8% and an EPS decline of about 11.5% at the midpoint. The CEO described renewed beer growth through stronger marketing, better brand execution and new products (Stocktwits).
4. DEEP DIVE ANALYSIS
Do fundamentals justify the move? Partly. The beat on EPS and revenue is clear, and the September comment gives investors a reason to believe the second-half guide is conservative. Depletions, the measure of consumer demand, still fell 0.6%, and the shipment growth came partly from distributors rebuilding inventory. Comparable EPS rose 3%, and GAAP operating income fell 8%. The stock trades on a forward P/E of 10.4 and a trailing P/E of 11.3 with a 3.36% dividend yield, so a low expectation base made a modest beat sufficient to move the shares.
Analyst reaction. Most brokers cut targets after the print, though several of the new targets sit above the $126.40 close.
| Broker | Action (date) | Target |
|---|---|---|
| Needham | Cut (8 Oct) | $150 from $185 |
| Piper Sandler | Cut (8 Oct) | $125 from $161 |
| Morgan Stanley | Cut (8 Oct) | $145 from $158 |
| UBS | Cut (8 Oct) | $144 from $145 |
| Deutsche Bank | Cut (8 Oct) | $127 from $136 |
| RBC | Cut, Buy kept (8 Oct) | $182 from $185 |
| Goldman Sachs | Cut, Buy kept (7 Oct) | $155 from $180 |
| JPMorgan | Raise, neutral kept (8 Oct) | $136 from $133 |
| HSBC | Downgrade to Hold (shown 7 Oct, 8:01pm ET) | Not in brief |
| BofA | Cut (7 Oct) | Level not in sources |
MarketBeat shows a Hold consensus with an average target of about $153 (The Cerbat Gem, 11 October); stockanalysis showed about $152 on 9 October. Brokers had already cut targets in September: Jefferies to $135, TD Cowen to $150 and Bernstein to $180. The target cuts therefore followed a period in which expectations had already come down, which is consistent with the stock rising despite them (inference).
Comparable episode. After the fiscal Q3 print, Goldman raised its target to $180 and called results "much better than feared" (Investing.com, dated 01/09/2026, read as 9 January though the day and month order is not stated). The October reaction follows a similar pattern of a low bar followed by a better-than-feared result.
Peers. Consumer staples peers also rose over the same period: WMT +7.62%, PM +6.58%, PG +4.97%, COST +3.89%, KO +3.79% and PEP +0.82%, while the S&P 500 gained 0.43%. STZ's 11.55% exceeds all of them. The brief found no sourced sector news explaining the staples rally, so part of the move may reflect a broader rotation into the group (inference). PepsiCo beat estimates but cut its full-year EPS outlook and rose only about 1% premarket on 8 October (Stocktwits). Just Drinks (12 October) describes the US beer market as stagnant.
Bull case. September depletions improve after the World Cup and August weakness, the guide moves toward its upper end, the spirit-based RTD category (up 25% in dollar sales over the past year, per the company) adds growth, and the valuation of 10.4 times forward earnings leaves room for re-rating.
Bear case. Depletions remain negative, the guide implies a steep second-half decline, inventory rebuilding flatters shipments, the US beer market is stagnant, and a Hold consensus with HSBC's downgrade shows analysts are not convinced.
5. TECHNICAL SNAPSHOT
The close of $126.40 sits just above the 50-day average of $125.75 and well below the 200-day average of $141.27. The price is $15.80 above the 52-week low of $110.60 set on 5 October, the day before the rally began, and $39.77 below the 52-week high of $166.17 from 13 April. The three sessions from 6 to 8 October ran on volume of 5.3 to 6.3 million shares, two to three times the 50-session average of 2,243,864, which points to institutional participation. The last session's volume of 2,393,000 was 1.07x the average, so the 12 October advance had little added participation. The nearest support is the 9 October close of $122.64, followed by the 8 October close of $123.63 as the upper edge of that area. The latest close is the highest in the table, so no resistance appears in the recent closes. The 200-day average is the next overhead reference.
6. RISK FACTORS
- The 12 October gain has no sourced driver and came on average volume, so it may not hold.
- RBC's September depletion call is sourced from a headline and partial summary and is unconfirmed as the driver of 8 October.
- Management's guidance implies a second-half beer sales decline of about 4.8% at the midpoint, so a shortfall against the "upper end" comment would hit sentiment.
- Depletions fell 0.6% and shipments rose 5.5%, a gap that normally closes through slower shipments if consumer demand does not recover.
- The consensus is Hold, and the downgrade and target cuts show limited conviction.
- The SpikedAde earn-out of up to $278 million runs over five years and adds ongoing performance checks (StockTitan).
- The next earnings date is not in the facts or the brief. The fiscal year ends 28 February 2027.
7. ACTIONABLE OUTLOOK
Short term (1-2 weeks). The stock has risen 11.55% in a week with the last session unexplained, so consolidation between the $122.64 close and the current level is a reasonable expectation (inference). A move through the 200-day average at $141.27 would need new evidence on September and October depletions. A close back below $122.64 would point to the rally fading.
Medium term (1-3 months). Direction depends on whether depletion data confirm the improvement management described for September. Positive readings would support targets near the Deutsche Bank ($127) to JPMorgan ($136) range and higher. Continued negative depletions would put the second-half guidance under pressure.
Long term. The thesis has not changed on the evidence in the brief. The company reaffirmed its guidance, returns capital, and trades at a low multiple, while the stagnant US beer market and negative depletions remain the central debate.
This is analysis only and not personal financial advice.